Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells.

BMC medicine·2024
Same author

Ursodeoxycholic acid alleviates atopic dermatitis-associated inflammatory responses in HaCaT and RBL-2H3 cells and DNCB/DFE-treated mice.

Life sciences·2024
Same author

Characteristics of a large outbreak arising from a school field trip after COVID-19 restrictions were eased in 2022.

Osong public health and research perspectives·2024
Same author

Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.

bioRxiv : the preprint server for biology·2024
Same author

Piperine improves the quality of porcine oocytes by reducing oxidative stress.

Free radical biology & medicine·2023
Same author

Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions of mast cells and T cells.

Scientific reports·2023

Related Experiment Video

Updated: Jun 21, 2026

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Fransje A Koning1, Edmund N C Newman, Eun-Young Kim

  • 1Department of Infectious Diseases, King's College London School of Medicine, United Kingdom.

Journal of Virology
|July 10, 2009
PubMed
Summary

Human APOBEC3G (A3G) and APOBEC3F (A3F) are key antiviral factors. A3G is more abundant than A3F, suggesting a greater role in inhibiting HIV-1. Both are induced by interferon, but protein levels vary by cell type.

More Related Videos

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis
11:50

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Published on: April 10, 2012

Related Experiment Videos

Last Updated: Jun 21, 2026

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis
11:50

Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis

Published on: April 10, 2012

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Human APOBEC3 enzymes are DNA cytidine deaminases with antiviral properties.
  • APOBEC3G (A3G) and APOBEC3F (A3F) inhibit HIV-1 but are counteracted by HIV-1 Vif.
  • These enzymes are expressed in various immune cells and tissues.

Purpose of the Study:

  • To comprehensively analyze the gene expression of human APOBEC3 enzymes, particularly A3G and A3F.
  • To understand the regulation of A3G and A3F expression in response to immune stimuli.
  • To compare the relative abundance and expression patterns of A3G and A3F.

Main Methods:

  • Quantification of mRNA copy numbers for A3G and A3F.
  • Analysis of gene expression in response to T-cell activation and cytokines (e.g., IFN-alpha, IFN-gamma).
  • Immunoblotting to assess protein levels of A3G.

Main Results:

  • A3G mRNA is approximately 10-fold more abundant than A3F mRNA.
  • A3G and A3F mRNA levels are significantly induced by IFN-alpha in macrophages and dendritic cells, and by IFN-alpha in naive CD4(+) T cells.
  • IFN-alpha induces A3G protein in macrophages and DCs, but not T cells; A3A expression is highly sensitive to IFN-alpha in multiple cell types.

Conclusions:

  • A3G is likely the predominant anti-HIV-1 factor in vivo due to its higher mRNA abundance.
  • Interferon-alpha plays a crucial role in inducing APOBEC3 expression in immune cells.
  • APOBEC3A may be involved in early innate antiviral responses, independent of HIV-1 inhibition.